Characterization of Patients with Asthma Initiating Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)

Real-world data characterizing patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) are limited; these data are important to complement findings from more stringent patient populations represented in initial FF/UMEC/VI efficacy studies.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research